Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASTROSTEM in Cerebral Palsy
NCT03979898Phase 1Completed
- Sponsor
- R Bio
- Start
- Jun 2017
- Primary completion
- Apr 2019
- Modality
- Mesenchymal Stem Cells, Patient-derived iPSCs, Allogeneic iPSCs
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of astrostem in cerebral palsy (CP), sponsored by R Bio. Primary endpoint: Kaufman Assessment Battery for Children at 12 months. Started Jun 2017; status: completed.
02
Drugs
astrostem
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT03979898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03979898.